RATIONALE: The endocannabinoid system is under active investigation as a pharmacological target for obesity management due to its role in appetite regulation and metabolism. Exogenous cannabinoids such as tetrahydrocannabinol (THC) stimulate appetite and food intake. However, there are no controlled observations directly linking THC to changes of most of the appetite hormones. OBJECTIVES: We took the opportunity afforded by a placebo-controlled trial of smoked medicinal cannabis for HIV-associated neuropathic pain to evaluate the effects of THC on the appetite hormones ghrelin, leptin and PYY, as well as on insulin. METHODS: In this double-blind cross-over study, each subject was exposed to both active cannabis (THC) and placebo. RESULTS: Compared to placebo, cannabis administration was associated with significant increases in plasma levels of ghrelin and leptin, and decreases in PYY, but did not significantly influence insulin levels. CONCLUSION: These findings are consistent with modulation of appetite hormones mediated through endogenous cannabinoid receptors, independent of glucose metabolism.
RCT Entities:
RATIONALE: The endocannabinoid system is under active investigation as a pharmacological target for obesity management due to its role in appetite regulation and metabolism. Exogenous cannabinoids such as tetrahydrocannabinol (THC) stimulate appetite and food intake. However, there are no controlled observations directly linking THC to changes of most of the appetite hormones. OBJECTIVES: We took the opportunity afforded by a placebo-controlled trial of smoked medicinal cannabis for HIV-associated neuropathic pain to evaluate the effects of THC on the appetite hormones ghrelin, leptin and PYY, as well as on insulin. METHODS: In this double-blind cross-over study, each subject was exposed to both active cannabis (THC) and placebo. RESULTS: Compared to placebo, cannabis administration was associated with significant increases in plasma levels of ghrelin and leptin, and decreases in PYY, but did not significantly influence insulin levels. CONCLUSION: These findings are consistent with modulation of appetite hormones mediated through endogenous cannabinoid receptors, independent of glucose metabolism.
Authors: V Di Marzo; S K Goparaju; L Wang; J Liu; S Bátkai; Z Járai; F Fezza; G I Miura; R D Palmiter; T Sugiura; G Kunos Journal: Nature Date: 2001-04-12 Impact factor: 49.962
Authors: Janice D Wagner; Li Zhang; Kylie Kavanagh; Gina M Ward; Janice E Chin; John R Hadcock; Bruce J Auerbach; H James Harwood Journal: J Pharmacol Exp Ther Date: 2010-07-06 Impact factor: 4.030
Authors: Ronald J Ellis; Will Toperoff; Florin Vaida; Geoffrey van den Brande; James Gonzales; Ben Gouaux; Heather Bentley; J Hampton Atkinson Journal: Neuropsychopharmacology Date: 2008-08-06 Impact factor: 7.853
Authors: Chukwuemeka N Okafor; Michael W Plankey; David Goodman-Meza; Michael Li; Karla J Bautista; Hector Bolivar; Tien C Phyllis; Todd T Brown; Steven J Shoptaw Journal: Drug Alcohol Depend Date: 2020-02-20 Impact factor: 4.492
Authors: Angela M Amedee; Whitney A Nichols; Nicole J LeCapitaine; Curtis Vande Stouwe; Leslie L Birke; Nedra Lacour; Peter J Winsauer; Patricia E Molina Journal: AIDS Res Hum Retroviruses Date: 2014-12 Impact factor: 2.205
Authors: Sofia Bouhlal; Kayla N Ellefsen; Mikela B Sheskier; Erick Singley; Sandrine Pirard; David A Gorelick; Marilyn A Huestis; Lorenzo Leggio Journal: Drug Alcohol Depend Date: 2017-08-31 Impact factor: 4.492
Authors: Ranganath Muniyappa; Sara Sable; Ronald Ouwerkerk; Andrea Mari; Ahmed M Gharib; Mary Walter; Amber Courville; Gail Hall; Kong Y Chen; Nora D Volkow; George Kunos; Marilyn A Huestis; Monica C Skarulis Journal: Diabetes Care Date: 2013-03-25 Impact factor: 19.112